ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

World-first swine-flu (adjuvanted) vaccine trial reveals one dose provides 'strong immune response' within two weeks

  [ 8 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 4, 2009


Previous research had indicated two doses of vaccine would be needed, but results from the first swine-flu vaccine trials being run by Leicester University in the UK reveal a strong immune response after just one dose.

[Underlining the importance of this finding, concurrent research at the University of Maryland suggests H1N1 will be the dominant strain this year because it is clearly more contagious/communicable than the two main “ordinary” seasonal flu strains. This is partly because it is so new that hosts haven’t had a chance to build immunity & offer resistance. While ordinary strains infect 5% to 20% of a population, the World Health Organization warns H1N1 could infect “as much as a third of the world’s population.”]

The Leicester pilot study involved 100 healthy volunteers, aged between 18 and 50.

Dr. Iain Stephenson, who led the trial at the Leicester Royal Infirmary employing vaccine developed by Norvartis, a Switzerland-based company, said: "The clinical trial of Novartis MF59-adjuvanted cell-based A (H1N1) vaccine indicates that the ‘swine flu’ vaccine elicits a strong immune response and is well-tolerated. Results showed that the serum antibody responses were highest among subjects who received two doses of vaccine; however, a single vaccine dose also induced responses associated with protection against influenza. [Adjuvanted vaccine “has material added to boost the immune response” - an approach the CDC says the US doesn’t anticipate using “at this time,” increasing the likelihood that two doses would be needed (though the US also has trials of adjuvanted vaccine underway).]

"The [Leicester] findings showed that it is possible to induce protective antibody against A(H1N1) infection within two weeks of administration of a single low-dose adjuvanted vaccine."

Non-adjuvanted formulations were not evaluated in this part of the study and will be evaluated shortly.
The trial evaluated the tolerability and immunogenicity of the vaccine, and tested different schedules of vaccination, in terms of time between vaccinations. The vaccine schedule was one or two doses of 7.5?g MF-59 adjuvanted surface-antigen A/California/2009 vaccine derived from cell-culture….

The research found the vaccine is well tolerated with pain at the injection site the most frequent adverse event….

Additional, larger pivotal trials with both cell culture and traditional egg based vaccines are already under way around the world that will include more than 6,000 adults and children. Timing on when the vaccine will be available to governments will depend on the results of these clinical trials, and approvals by regulatory authorities.

Source: University of Leicester news release Sep 3, 2009




Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Breakthrough Form of Magnesium Enhances Memory and Cognitive Function Breakthrough Form of Magnesium Enhances Memory and Cognitive Function
Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map